Publication:
Scar among Bacillus Calmette-Guérin Vaccinated Children Presenting to an Immunisation Clinic at a Tertiary Hospital in Nepal: An Observational Study

creativeworkseries.issnJNMA Print ISSN: 0028-2715; Online ISSN: 1815-672X
dc.contributor.authorDhakal, Ajaya Kumar
dc.contributor.authorKC, Divya
dc.contributor.authorShrestha, Barsha
dc.contributor.authorShrestha, Devendra
dc.contributor.authorNeupane, Nischal
dc.contributor.authorAcharya, Sharda
dc.contributor.authorShrestha, Saurav
dc.date.accessioned2025-07-27T09:54:07Z
dc.date.available2025-07-27T09:54:07Z
dc.date.issued2025
dc.descriptionAjaya Kumar Dhakal Department of Paediatrics, KIST Medical College and Teaching Hospital, Imadol, Lalitpur, Nepal Divya KC Department of Paediatrics, KIST Medical College and Teaching Hospital, Imadol, Lalitpur, Nepal Barsha Shrestha Department of Paediatrics, KIST Medical College and Teaching Hospital, Imadol, Lalitpur, Nepal Devendra Shrestha Department of Paediatrics, KIST Medical College and Teaching Hospital, Imadol, Lalitpur, Nepal Nischal Neupane Department of Paediatrics, KIST Medical College and Teaching Hospital, Imadol, Lalitpur, Nepal Sharda Acharya Department of Paediatrics, KIST Medical College and Teaching Hospital, Imadol, Lalitpur, Nepal Saurav Shrestha Department of Paediatrics, KIST Medical College and Teaching Hospital, Imadol, Lalitpur, Nepal
dc.description.abstractAbstract Introduction: Bacillus Calmette-Guérin vaccination is associated with the development of scarring at the vaccination site in most children within 12 weeks of vaccination. However, due to various factors, some children do not develop scars. The aim of the study was to determine the prevalence of scar failure and the differences in clinical characteristics between scar-positive and scar-negative children. Methods: This observational cross-section study was conducted between 12 September 2022 and 15 April 2024 on children attending a vaccination clinic at a tertiary care hospital for 12 or 15-month vaccination. A purposive sampling method was used, and 386 children were enrolled in the study. During medical history, information was collected on Bacillus Clamettte-Guérin vaccination, child and maternal clinical profiles, and hospitalisations for respiratory tract infections in children. Results: Among 386 infants, prevalence of BCG scar was 341 (88.34%; 95% CI: 91.81%-91.37%). Vaccination was confirmed in 94.82% by history and card. The median scar size was 4mm (IQR: 2,5 mm) transversely and 3 mm (IQR: 2,5) vertically. Thirty-two (8.30%) infants required hospital admission for respiratory infections; none received anti-tubercular treatment. Conclusions: The BCG scar formation was higher compare to the scar failure. The scar failure was comparable to other studies.
dc.identifierhttps://doi.org/10.31729/jnma.9025
dc.identifier.urihttps://hdl.handle.net/20.500.14572/777
dc.language.isoen_US
dc.publisherNepal Medical Association
dc.titleScar among Bacillus Calmette-Guérin Vaccinated Children Presenting to an Immunisation Clinic at a Tertiary Hospital in Nepal: An Observational Study
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage308
oaire.citation.startPage303
relation.isJournalIssueOfPublicatione807a5eb-c16f-42e2-84b2-cd15ef664de9
relation.isJournalIssueOfPublication.latestForDiscoverye807a5eb-c16f-42e2-84b2-cd15ef664de9
relation.isJournalOfPublicatione6e146a0-0ece-4aba-aa0a-6ccfbd10a12a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
303-308.pdf
Size:
200.22 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections